Tectonic Therapeutic (TECX) Non-Current Debt (2021 - 2023)
Tectonic Therapeutic (TECX) posted quarterly Non-Current Debt of $15.4 million for Q1 2023, up 2.24% year-over-year from $15.0 million in Q1 2022, and up 0.52% quarter-over-quarter from $15.3 million in Q4 2022.
Tectonic Therapeutic (TECX) Non-Current Debt (2021 - 2023) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Non-Current Debt for 3 consecutive years, with $15.4 million the latest figure, recorded in Q1 2023.
- In Q1 2023, Non-Current Debt rose 2.24% year-over-year to $15.4 million; the TTM figure through Mar 2023 stood at $15.4 million (up 2.24% YoY), while the FY2022 annual figure was $15.3 million, up 2.21% from the prior year.
- Non-Current Debt improved to $15.4 million in Q1 2023 per TECX's latest filing, from $15.3 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $15.4 million in Q1 2023 and bottomed at $14.9 million in Q4 2021.
- Historically, Non-Current Debt has averaged $15.2 million across 3 years, with a median of $15.2 million in 2022.
- Annual changes were most pronounced in 2022 — Non-Current Debt gained 2.21% — and 2023, when it rose 2.24%.
- Tectonic Therapeutic's Non-Current Debt stood at $14.9 million in 2021, then rose by 2.21% to $15.3 million in 2022, then rose by 0.52% to $15.4 million in 2023.
- Business Quant data shows TECX's Non-Current Debt at $15.4 million in Q1 2023, $15.3 million in Q4 2022, and $15.2 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 882.16 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 8.96 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 15.36 Mn |
| Dec 31, 2022 | 15.28 Mn |
| Sep 30, 2022 | 15.21 Mn |
| Jun 30, 2022 | 15.10 Mn |
| Mar 31, 2022 | 15.02 Mn |
| Dec 31, 2021 | 14.95 Mn |